News

Ideas That Generate Results

According to a new research report by RNCOS entitled, “US Proton Therapy Market Outlook 2020”, US industry has been witnessing higher growth in proton therapy, in 2014, US proton therapy market was generating approximately US$ 640 Million in revenue. Due to increased government support, rise in incidence of cancer and side effects of traditional radiation therapies, the proton therapy has gained popularity.
 
However, the industry faces some challenges such as low awareness, high prices and reimbursement issues. A company like IBA Group is considered to be the dominant player whereas other large players in the market are Varian, Hitachi and Mevion Medical Systems.
 
The report is spread in over 70 pages and provides an in-depth research and rational analysis of the current status and future prospect of the US Proton Therapy Industry. The study presents a transparent picture about different cancer incidence facts such as the number of cancer deaths by state and site. Each proton therapy center in the country has been evaluated sincerely, to estimate the shortage of number of centers in the each state. The research further covers current radiation therapies available in the market, detailed analysis of potential cancer patients by each state (2014 & 2020), Growth Drivers and Challenges as well as the industry trends.
 
The report also covers detailed information about active market players in the US proton therapy industry, including domestic and foreign players to enable the clients to understand the market structure and its growth during the forecasted period. In brief, the report covers all the necessary aspects of the US Proton Therapy industry, providing an in-depth research and prudent analysis of the key segments.
 
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM763.htm
 
Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm